An alternative view of homocysteine

Lancet. 1999 Dec 11;354(9195):2072-4. doi: 10.1016/S0140-6736(99)03383-8.

Author

N P Dudman¹

Affiliation

¹ Faculty of Medicine, Centre for Thrombosis and Vascular Research, University of New South Wales, Prince of Wales Hospital, Randwick, Australia.

PMID: 10636386
DOI: 10.1016/S0140-6736(99)03383-8

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Arterial Occlusive Diseases / blood
Arterial Occlusive Diseases / etiology*
Arterial Occlusive Diseases / prevention & control
Coronary Disease / blood
Coronary Disease / etiology
Coronary Disease / prevention & control
Homocysteine / blood
Humans
Hyperhomocysteinemia / complications*
Hyperhomocysteinemia / etiology
Hyperhomocysteinemia / prevention & control
Myocardial Infarction / blood
Myocardial Infarction / etiology
Myocardial Infarction / prevention & control
Risk Factors

Substances

Homocysteine